Vermillion Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Sell
692
-124
-15% -$26.7K 0.04% 269
2026
Q1
$177K Buy
816
+124
+18% +$27.5K 0.07% 102
2025
Q4
$158K Hold
692
0.06% 110
2025
Q3
$160K Buy
692
+5
+0.7% +$1.02K 0.04% 265
2025
Q2
$128K Hold
687
0.06% 109
2025
Q1
$144K Hold
687
0.04% 248
2024
Q4
$122K Buy
+687
New +$126K 0.06% 114

Other funds holding ABBV

Vermillion Wealth Management's ABBV Position: Q2 2026 in Review

Vermillion Wealth Management reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $26.7K and leaving 692 shares worth $174K. The position accounts for 0.04% of the portfolio, ranked #269.

Vermillion Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $177K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vermillion Wealth Management held 692 shares of AbbVie worth $174K as of Q2 2026.
  • Vermillion Wealth Management sold 124 AbbVie shares in Q2 2026, an estimated $26.7K.
  • AbbVie made up 0.04% of Vermillion Wealth Management's portfolio in Q2 2026, its #269 holding.
  • Vermillion Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's AbbVie position peaked at $177K in Q1 2026.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.